Coming soonPT-141 · sublingual or buccal troche
Desire that feels like yours again.
PT-141 is designed to help restore sexual desire in premenopausal women. Rebody’s needle-free troche is coming soon. Orders aren’t open yet.
Get troche updatesJoin the list for price, directions, package details, and states served.
2strength options
Mini trocheneedle-free format
Refrigeratedstorage
When desire goes quiet
When desire goes quiet, trying harder rarely makes it louder.
Low desire can feel distant from the rest of you: affection is still there, the relationship may be good, but desire is not arriving the way it used to. Bremelanotide activates melanocortin receptors involved in sexual desire.
See the study scope →Coming-soon strengths
A small troche that dissolves under the tongue or between gum and cheek.
Orders are closed. Join the list for directions, price, states served, and refill timing.
Bremelanotide injection trials
1,267 women. Two phase 3 trials. Twenty-four weeks.
The RECONNECT trials randomized premenopausal women with HSDD to 1.75 mg subcutaneous bremelanotide or placebo as needed. The measured outcomes were desire and distress related to low desire.
Inside the mouth
Two placement optionsUnder the tongue or between cheek and gum.
The mini troche dissolves in the mouth. Sublingual means under the tongue; buccal means between the gum and cheek.
The prescription label will specify placement, timing, maximum frequency, strength, and flavor.
Bremelanotide injection safety
Not for uncontrolled high blood pressure or cardiovascular disease.
Another needle-free format
PT-141 nasal spray is coming soon too.
A refrigerated 5 mL bottle with metered nasal-spray delivery.
PT-141 Troches updates
Be first to know when orders open.
We’ll email the price, directions, package, and states served.
Coming soonOrders currently closed
PT-141 troche launch updates.
Get the price, directions, package details, and states served.
Product updates and occasional emails. Unsubscribe anytime.